Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Teams with US, Italian Researchers for CVD, Hypertension Signatures

NEW YORK (GenomeWeb News) - Beckman Coulter has started a research collaboration with Thomas Jefferson University of Philadelphia and the Laboraf Diagnostica e Ricerca San Raffaele in Milan, Italy, aimed at researching genetic signatures for cardiovascular disease and obesity-related hypertension.
Under the collaboration, the universities and the company will use the company's Biomek FXP Laboratory Automation Workstation and GenomeLab SNPStream Genotyping System to develop research protocols and assays. Beckman Coulter will have the right to exclusively license commercial applications that result from the collaboration.
Beckman intends to use the genetic signatures discovered in the alliance to develop content for its next-generation molecular diagnostics platform, which it plans to launch in 2010.
“The discovery of genetic factors for both CVD and obesity may lead to development of readily-accessible diagnostic tests that enable more rapid assessment, earlier treatment, and preventive measures,” Bruce Wallace, president of Beckman Coulter’s molecular diagnostics business center, said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more